Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Lucas

Showing results (761-770 of 992) with videos related to

Pageof 100
Sort By:
Journal of the American Chemical Society|July 30, 2025
Modular Synthetic Platform for the Elaboration of Fragments in Three Dimensions for Fragment-Based Drug DiscoveryAndres R Gomez-Angel, Hanna F Klein, Stephen Y Yao, et al.
Nucleic Acids Research|March 7, 2023
Dynamic interplay between RPL3- and RPL3L-containing ribosomes modulates mitochondrial activity in the mammalian heartIvan Milenkovic, Helaine Graziele Santos Vieira, Morghan C Lucas, et al.
Bioorganic & Medicinal Chemistry Letters|August 25, 2009
Potent and cellularly active 4-aminoimidazole inhibitors of cyclin-dependent kinase 5/p25 for the treatment of Alzheimer's diseaseChristopher J Helal, Zhijun Kang, John C Lucas, et al.
Nature Biotechnology|May 14, 2021
Quantitative profiling of pseudouridylation dynamics in native RNAs with nanopore sequencingOguzhan Begik, Morghan C Lucas, Leszek P Pryszcz, et al.
Cancer Cell|August 4, 2009
Persistence of leukemia-initiating cells in a conditional knockin model of an imatinib-responsive myeloproliferative disorderKatherine I Oravecz-Wilson, Steven T Philips, Omer H Yilmaz, et al.
Science (New York, N.Y.)|January 29, 2011
Cleavage of NIK by the API2-MALT1 fusion oncoprotein leads to noncanonical NF-kappaB activationShaun Rosebeck, Lisa Madden, Xiaohong Jin, et al.
Cancer Chemotherapy and Pharmacology|March 6, 1998
Phase I clinical and pharmacokinetic study of S9788, a new multidrug-resistance reversal agent given alone and in combination with doxorubicin to patients with advanced solid tumorsB Tranchand, G Catimel, C Lucas, et al.
BMC Cancer|September 25, 2016
Epicure: a European epidemiological study of patients with an advanced or metastatic Urothelial Carcinoma (UC) having progressed to a platinum-based chemotherapyN Houédé, G Locker, C Lucas, et al.
The Journal of Infectious Diseases|December 9, 2000
Protection of Aotus monkeys by Plasmodium falciparum EBA-175 region II DNA prime-protein boost immunization regimenT R Jones, D L Narum, A S Gozalo, et al.
Actas Urologicas Espanolas|December 7, 2018
Incidence of surgical wound infection in renal surgery. The effect of antibiotic prophylaxis appropriateness. A prospective cohort studyM Alonso-García, J M de-la-Morena, E de-la-Peña, et al.
Pageof 100

Showing results (761-770 of 992) with videos related to

Sort By:
Pageof 100
Journal of the American Chemical Society|July 30, 2025
Modular Synthetic Platform for the Elaboration of Fragments in Three Dimensions for Fragment-Based Drug DiscoveryAndres R Gomez-Angel, Hanna F Klein, Stephen Y Yao, et al.
Nucleic Acids Research|March 7, 2023
Dynamic interplay between RPL3- and RPL3L-containing ribosomes modulates mitochondrial activity in the mammalian heartIvan Milenkovic, Helaine Graziele Santos Vieira, Morghan C Lucas, et al.
Bioorganic & Medicinal Chemistry Letters|August 25, 2009
Potent and cellularly active 4-aminoimidazole inhibitors of cyclin-dependent kinase 5/p25 for the treatment of Alzheimer's diseaseChristopher J Helal, Zhijun Kang, John C Lucas, et al.
Nature Biotechnology|May 14, 2021
Quantitative profiling of pseudouridylation dynamics in native RNAs with nanopore sequencingOguzhan Begik, Morghan C Lucas, Leszek P Pryszcz, et al.
Cancer Cell|August 4, 2009
Persistence of leukemia-initiating cells in a conditional knockin model of an imatinib-responsive myeloproliferative disorderKatherine I Oravecz-Wilson, Steven T Philips, Omer H Yilmaz, et al.
Science (New York, N.Y.)|January 29, 2011
Cleavage of NIK by the API2-MALT1 fusion oncoprotein leads to noncanonical NF-kappaB activationShaun Rosebeck, Lisa Madden, Xiaohong Jin, et al.
Cancer Chemotherapy and Pharmacology|March 6, 1998
Phase I clinical and pharmacokinetic study of S9788, a new multidrug-resistance reversal agent given alone and in combination with doxorubicin to patients with advanced solid tumorsB Tranchand, G Catimel, C Lucas, et al.
BMC Cancer|September 25, 2016
Epicure: a European epidemiological study of patients with an advanced or metastatic Urothelial Carcinoma (UC) having progressed to a platinum-based chemotherapyN Houédé, G Locker, C Lucas, et al.
The Journal of Infectious Diseases|December 9, 2000
Protection of Aotus monkeys by Plasmodium falciparum EBA-175 region II DNA prime-protein boost immunization regimenT R Jones, D L Narum, A S Gozalo, et al.
Actas Urologicas Espanolas|December 7, 2018
Incidence of surgical wound infection in renal surgery. The effect of antibiotic prophylaxis appropriateness. A prospective cohort studyM Alonso-García, J M de-la-Morena, E de-la-Peña, et al.
Pageof 100